摘要
目的分析探讨足月急性呼吸窘迫综合征新生儿的临床治疗体会。方法选取2016年8月至2018年8月在我院接受急性呼吸窘迫综合征的足月新生儿180例,随机分为两组,每组各90例患儿,其中一组患儿给予经鼻持续性正压通气治疗模式设为通气组,给予另一组患儿肺泡表面活性剂联合经鼻持续性正压通气治疗模式进行治疗设为实验组,对比两组患儿的临床治疗效果。结果实验组总体治疗有效率为96.7%,通气组总体治疗有效率为87.8%,实验组总体治疗有效率明显高于通气组(P<0.05)。结论在足月急性呼吸窘迫综合征新生儿的治疗中采用肺泡表面活性剂联合经鼻持续性正压通气治疗模式,有着较好的临床治疗效果,值得在临床上大力的推广实行。
Objective To analyze the clinical experience of neonates with full-term acute respiratory distress syndrome. Methods Full-term neonates 180 with acute respiratory distress syndrome were enrolled in our hospital from August 2016 to August 2018. They were randomly divided into two groups, 90 children in each group, and one group was given The nasal continuous positive pressure ventilation treatment mode was set as the ventilation group, and the other group of children with alveolar surfactant combined with nasal continuous positive pressure ventilation treatment was used as the experimental group. The clinical treatment effect of the two groups was compared. Results The overall treatment effective rate was 96.7% in the experimental group and 87.8% in the ventilation group. The overall treatment efficiency of the experimental group was significantly higher than that of the ventilation group(P< 0.05). Conclusion Alveolar surfactant combined with nasal continuous positive pressure ventilation in the treatment of fullterm acute respiratory distress syndrome in neonates has a good clinical effect and is worthy of clinical promotion.
作者
张磊
王兆富
ZHANG Lei;WANG Zhao-fu(Division of Neonatology,Weifang Women's and Children's Health Hospital,Weifang,Shandong 261011;Department of Ultrasound,Weifang Women and Children's Health Hospital,Weifang,Shandong 261011)
出处
《智慧健康》
2018年第28期137-138,共2页
Smart Healthcare
关键词
足月急性呼吸窘迫综合征
经鼻持续性正压通气治疗模式
肺泡表面活性剂
Full-term acute respiratory distress syndrome
Nasal continuous positive pressure ventilation treatment mode
Alveolar surfactant
